Alder BioPharmaceuticals - 48 Year Dividend History | ALDR

Historical dividend payout and yield for Alder BioPharmaceuticals (ALDR) since 1971. The current TTM dividend payout for Alder BioPharmaceuticals (ALDR) as of June 17, 2019 is $0.00. The current dividend yield for Alder BioPharmaceuticals as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.005B $0.002B
Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83